{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:44:49Z","timestamp":1787669089441,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.yexmp.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T07:33:51Z","timestamp":1498548831000},"page":"33-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Mutational analysis in BCR - ABL1 positive leukemia by deep sequencing based on nanopore MinION technology"],"prefix":"10.1016","volume":"103","author":[{"given":"Crescenzio F.","family":"Minervini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Cumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Anelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zagaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Impera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Coccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Casieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Tota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Russo Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Specchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2017.06.007_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cancergencyto.2006.09.025","article-title":"\u201cHome-brew\u201d FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia","volume":"174","author":"Albano","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.yexmp.2017.06.007_bb0010","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/onc.2009.524","article-title":"Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia","volume":"29","author":"Albano","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/jmg.2010.082081","article-title":"GeneScreen: a program for high-throughput mutation detection in DNA sequence electropherograms","volume":"48","author":"Carr","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.yexmp.2017.06.007_bb0020","first-page":"93","article-title":"ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia","author":"Ernst","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0025","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/bioinformatics\/bts503","article-title":"Qualimap: evaluating next-generation sequencing alignment data","volume":"28","author":"Garcia-Alcalde","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0030","series-title":"Visualizing Genomic Data Using Gviz and Bioconductor","first-page":"335","author":"Hahne","year":"2016"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0035","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.leu.2404318","article-title":"Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/cncr.23666","article-title":"Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors","volume":"113","author":"Jones","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gpb.2016.05.004","article-title":"Oxford nanopore MinION sequencing and genome assembly. genomics","volume":"14","author":"Lu","year":"2016","journal-title":"Proteomics Bioinform."},{"key":"10.1016\/j.yexmp.2017.06.007_bb0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00432-014-1845-6","article-title":"Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase","volume":"141","author":"Machova Polakova","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2017.06.007_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13000-016-0550-y","article-title":"TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing","volume":"11","author":"Minervini","year":"2016","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.yexmp.2017.06.007_bb0060","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/bjc.2013.318","article-title":"BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance","volume":"109","author":"Parker","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0065","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2015-09-666214","article-title":"The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib","volume":"127","author":"Parker","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0075","first-page":"118","article-title":"BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet","author":"Soverini","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0080","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-03-487728","article-title":"Unraveling the complexity of tyrosine kinase inhibitor\u2013resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain","volume":"122","author":"Soverini","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0085","doi-asserted-by":"crossref","first-page":"21982","DOI":"10.18632\/oncotarget.8010","article-title":"Next-generation sequencing for sensitive detection of BCRABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients","volume":"7","author":"Soverini","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexmp.2017.06.007_bb0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00277-015-2539-0","article-title":"Detection of BCR-ABL1 mutations that confer tyrosine kinase inhibitor resistance using massively parallel, next generation sequencing","volume":"95","author":"Szankasi","year":"2016","journal-title":"Ann. Hematol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480017301995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480017301995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T10:25:13Z","timestamp":1535711113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480017301995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0014480017301995"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.06.007","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}